DR. JOHN HARRISON KRYSTAL, M.D.
Psychiatric at Campbell Ave, New Haven, CT
License number
Connecticut 027473
Category
Psychiatric
Type
Psychiatry
License number
Connecticut 027473
Category
Psychiatric
Type
Addiction Psychiatry
Address
Address
950 Campbell Ave, New Haven, CT 06516
Phone
(203) 937-4790
(203) 937-3468 (Fax)
(203) 393-2604
(203) 393-1086 (Fax)
(203) 937-3468 (Fax)
(203) 393-2604
(203) 393-1086 (Fax)
Personal information
See more information about JOHN HARRISON KRYSTAL at radaris.comName
Address
Phone
119 Maplevale Dr, Woodbridge, CT 06525
106 Livingston St, New Haven, CT 06511
112 Livingston St #C2, New Haven, CT 06511
119 Maplevale Dr, Woodbridge, CT 06525
119 Maplewood Terrace Ext, Hamden, CT 06514
Professional information
See more information about JOHN HARRISON KRYSTAL at trustoria.com
John Harrison Krystal, West Haven CT
John Harrison Krystal, West Haven CT
Specialties:
Psychiatrist
Address:
950 Campbell Ave, West Haven, CT 06516
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)
Dr. John H Krystal, New Haven CT - MD (Doctor of Medicine)
Dr. John H Krystal, New Haven CT - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
Yale University Psychiatry
300 George St SUITE 901, New Haven 06511
(203) 785-2018 (Phone)
VA Cnnctct Hlthcr Sys Psychtry
950 Campbell Ave SUITE 116A, West Haven 06516
(203) 932-5711 (Phone)
300 George St SUITE 901, New Haven 06511
(203) 785-2018 (Phone)
VA Cnnctct Hlthcr Sys Psychtry
950 Campbell Ave SUITE 116A, West Haven 06516
(203) 932-5711 (Phone)
Certifications:
Psychiatry, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Yale University Psychiatry
300 George St SUITE 901, New Haven 06511
VA Cnnctct Hlthcr Sys Psychtry
950 Campbell Ave SUITE 116A, West Haven 06516
Yale - New Haven Hospital
20 York St, New Haven 06510
300 George St SUITE 901, New Haven 06511
VA Cnnctct Hlthcr Sys Psychtry
950 Campbell Ave SUITE 116A, West Haven 06516
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Yale University
Graduated: 1984
Hospital Of St Raphael
Graduated: 1985
Yale University
Graduated: 1984
Hospital Of St Raphael
Graduated: 1985
Dopamine And Noradrenergic Reuptake Inhibitors In Treatment Of Schizophrenia
Dopamine And Noradrenergic Reuptake Inhibitors In Treatment Of Schizophrenia
US Patent:
5447948, Sep 5, 1995
Filed:
May 7, 1992
Appl. No.:
7/880127
Inventors:
John P. Seibyl - Branford CT
John H. Krystal - New Haven CT
Dennis S. Charney - Hamden CT
John H. Krystal - New Haven CT
Dennis S. Charney - Hamden CT
Assignee:
Yale University - New Haven CT
International Classification:
A61K 31415, A61K 31445
US Classification:
514393
Abstract:
Mazindol and other dopamine and/or noradrenergic reuptake inhibitors are effective to treat negative symptoms in schizophrenia.
Intranasal Administration Of Ketamine To Treat Depression
Intranasal Administration Of Ketamine To Treat Depression
US Patent:
2007028, Dec 13, 2007
Filed:
Mar 20, 2007
Appl. No.:
11/688603
Inventors:
Dennis Charney - Chappaqua NY, US
Sanjay Mathew - New York NY, US
Husseini Manji - Rockville MD, US
Carlos Zarate - Germantown MD, US
John Krystal - Woodbridge CT, US
Sanjay Mathew - New York NY, US
Husseini Manji - Rockville MD, US
Carlos Zarate - Germantown MD, US
John Krystal - Woodbridge CT, US
Assignee:
MOUNT SINAI SCHOOL OF MEDICINE - New York NY
NATIONAL INSTITUTE OF HEALTH - Rockville MD
YALE UNIVERSITY SCHOOL OF MEDICINE - New Haven CT
NATIONAL INSTITUTE OF HEALTH - Rockville MD
YALE UNIVERSITY SCHOOL OF MEDICINE - New Haven CT
International Classification:
A61K 31/135, A61K 33/14, A61K 36/00, A61M 11/00, A61M 5/00, A61P 25/24
US Classification:
514647000, 128200140, 424449000, 424722000, 424725000, 604046000
Abstract:
Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
Glutamate Agents In The Treatment Of Mental Disorders
Glutamate Agents In The Treatment Of Mental Disorders
US Patent:
2006027, Nov 30, 2006
Filed:
Apr 5, 2006
Appl. No.:
11/399188
Inventors:
Vladimir Coric - Madison CT, US
John Krystal - Woodbridge CT, US
Gerard Sanacora - Guilford CT, US
John Krystal - Woodbridge CT, US
Gerard Sanacora - Guilford CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 31/43, A61K 31/545, A61K 31/485, A61K 31/198, A61K 31/13
US Classification:
514192000, 514200000, 514562000, 514282000, 514649000, 514663000
Abstract:
Methods of treating mental disorders, including anxiety disorders such as obsessive-compulsive disorder, are provided. The methods comprise administering an effective amount of a glutamate modulator to an individual in need thereof. Also provided are methods of enhancing the activity of a serotonin reuptake inhibitor (SRI) comprising co-administering a glutamate modulator and a serotonin reuptake inhibitor. Pharmaceutical composition comprising a serotonin reuptake inhibitor and a glutamate modulator are also provided.